Tenon Medical (TNON) Cash & Equivalents (2021 - 2026)

Tenon Medical's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 55.32% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 55.32% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 42.52% from the prior year.
• Cash & Equivalents rose to $4.6 million in Q1 2026 per TNON's latest filing, from $3.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $10.3 million in Q1 2025 and bottomed at $2.0 million in Q2 2024.
• The 5-year median for Cash & Equivalents is $4.4 million (2024), against an average of $5.0 million.
• Across the five-year window, Cash & Equivalents slumped 66.37% in 2024 and surged 298.68% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $2.1 million in 2022, then climbed by 14.04% to $2.4 million in 2023, then jumped by 169.15% to $6.5 million in 2024, then plunged by 42.52% to $3.8 million in 2025, then gained by 22.66% to $4.6 million in 2026.
• Per Business Quant, the three latest TNON Cash & Equivalents figures stand at $4.6 million (Q1 2026), $3.8 million (Q4 2025), and $3.4 million (Q3 2025).